Zdrowie i gospodarka · 1.08.2014
Draft Guidance for Industry on Cell-Based Products for Animal Use; Availability
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry #218 entitled "Cell-Based Products for Animal Use." This draft guidance describes FDA's Center for Veterinary Medicine's (CVM) current thinking on cell- based products for animal use that meet the definition of a new animal drug. This draft guidance is for firms and individuals developing cell- based products, including animal stem cell-based products (ASCPs).